Tianjin Ringpu Bio-Technology Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Ringpu Bio-Technology Co Ltd with three other
companies in this sector in China:
Jiangxi Boya Bio-Pharmaceutical Co Ltd
sales of 543.10 million Chinese Renmimbi [US$78.89 million]
of which 63%
was Blood Plasma),
Chongqing Zhifei Biological Products Co Ltd
(711.35 million Chinese Renmimbi [US$103.33 million]
of which 99%
was Biological Product), and
Walvax Biotechnology Company Limited
(1.01 billion Chinese Renmimbi [US$146.04 million]
of which 58%
was Vaccine Product Subcontract).
During the year ended December of 2015, sales at
Tianjin Ringpu Bio-Technology Co Ltd were 792.32 million Chinese Renmimbi (US$115.09 million).
increase of 35.4%
versus 2014, when the company's sales were 585.12 million Chinese Renmimbi.
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
364.8% in 2015, from
3.44 million Chinese Renmimbi to 15.97 million Chinese Renmimbi.
Tianjin Ringpu Bio-Technology Co Ltd also saw significant increases in sales in
Veterinary Biological Products (up 46.4% to 475.22 million Chinese Renmimbi)